平痞汤联合雷贝拉唑治疗脾胃湿热型慢性非萎缩性胃炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R573.3+1

基金项目:


Clinical Study on Pingpi Tang Combined with Rabeprazole for Chronic Non-Atrophic Gastritis of Spleen and Stomach Damp-Heat Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察平痞汤联合雷贝拉唑治疗脾胃湿热型慢性非萎缩性胃炎(CNAG)的临床疗效。方法:将脾胃湿热型 CNAG患者 114 例按照随机数字表法分为观察组和对照组,各 57 例。对照组给予雷贝拉唑治疗,观察组在对照组的基础上联合平痞汤 治疗,疗程均为 4 周。记录 2 组临床疗效及 Hp 清除率,比较 2 组患者治疗前后中医证候(脘腹痞满、胃脘隐痛、嗳气反酸、纳呆食少、恶心呕吐、神疲乏力) 积分、血清表皮生长因子 (EGF)、一氧化氮 (NO)、白细胞介素-6 (IL-6)、肿瘤坏死因子-α (TNF-α)、γ 干扰素(IFN-γ)水平变化情况。结果:观察组总有效率为 96.49%,对照组为 85.96%,2 组比较,差异有统计学意义(P<0.05)。治疗后,2 组脘腹痞满、胃脘隐痛、嗳气反酸、纳呆食少、恶心呕吐、神疲乏力等证候积分及总积分均低于治疗前 (P<0.05),且观察组各项积分低于对照组 (P<0.05)。治疗后,2 组血清 EGF、IL-6、TNF-α、IFN-γ 水平较治疗前降低(P<0.05),NO 水平较治疗前升高 (P<0.05);且观察组上述指标改善较对照组更显著 (P<0.05)。观察组 Hp 清除率为68.42%,对照组为 49.12%,2 组比较,差异有统计学意义 (P<0.05)。结论:平痞汤联合雷贝拉唑治疗脾胃湿热型 CNAG 疗效显著,能有效改善患者临床症状,减轻炎症损伤,提高 Hp 清除率。

    Abstract:

    Abstract:Objective:To observe the clinical effect of the therapy of Pingpitang combined with rabeprazole on chronic non-atrophic gastritis (CNAG) of spleen and stomach damp-heat type. Methods:A total of 114 CNAG patients of spleen and stomach damp-heat typewere divided into the observation group and the control group according to the random number table method,57 cases in each group.The control group was treated with rabeprazole,and the observation group was treated with Pingpitang based on the treatment of the control group;both groups were treated for four weeks. The clinical curative effect and Hp clearance ratein the two groups were recorded;before and after treatment,the changes in the scores of Chinese medicine syndromes such as distention and fullness in the stomach cavity and abdomen,dull pain in the stomach cavity, belching and sour regurgitation,poor appetite,nausea and vomiting as well as mental fatigue and lack of strength,and thelevels of serum epidermal growth factor (EGF),nitric oxide (NO),interleukin-6 (IL-6),tumor necrosis factor-α(TNF-α) and interferon-γ(IFN-γ) in the two groups were compared. Results:The total effective rate was 96.49% in the observation group and 85.96% in the control group,the difference being significant(P<0.05). After treatment,the scores of distention and fullness in the stomach cavity and abdomen, dull pain in the stomach cavity, belching and sour regurgitation, poor appetite,nausea and vomiting as well as mental fatigue and lack of strengthand the total scores in the two groups were lower than those before treatment(P<0.05),and the above scores in the observation group were lower than those in the control group(P<0.05). After treatment,the levels of serum EGF,IL-6,TNF-α and IFN-γ in the two groups were decreased when compared with those before treatment(P<0.05), and the levels of NOin the two groupswere increased(P<0.05); the improvement of the above indexes in the observation group was more significant than that in the control group(P<0.05). The Hp clearance rate was 68.42% in the observation group and 49.12% in the control group,the difference being significant(P< 0.05). Conclusion: The therapy of Pingpitang combined with rabeprazole has a significant effect on CNAG of spleen and stomach damp-heat type,which can effectively improve the clinical symptoms of patients,reduce inflammatory damage, and improve the Hp clearance rate.

    参考文献
    相似文献
    引证文献
引用本文

王小龙.平痞汤联合雷贝拉唑治疗脾胃湿热型慢性非萎缩性胃炎临床研究[J].新中医,2021,53(4):81-84

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-02-27
  • 出版日期:
文章二维码